Intro to the Healthcare Renaissance

November 11, 2022
This election season (like every election season, it seems) has been a wild one.

But our team was tracking results in Colorado very closely – and it’s probably not the race you’re thinking of.

I’m talking about psychedelics.
Proposition 122 passed by slim margins, and will allow for the cultivation of psilocybin mushrooms and create state-regulated centers where consumers can make appointments to consume it. 

Advocates for psilocybin tout the substance’s affinity to treat many mental health conditions, including depression and anxiety when taken in small doses…small enough to achieve the desired health benefits but also prevent the “trippy” effects most people think of when they think of magic mushrooms. 

This method is called microdosing and it’s one of the fastest-growing trends in the LikeFolio universe.
Discussions surrounding the topic are exploding, and the sample size is nothing to scoff at. We logged more than 100,000 of these topical discussions last quarter alone. 

Despite this surge in interest, this trend is still in the very early stages of development. 

Colorado, after all, is only the second state (behind Oregon) to legalize access to psilocybin in this nature. 

But as an investor, it’s something to watch. 

This treatment could serve as a solution for many consumers with mental health concerns – many of which have risen dramatically as a result of the pandemic.

So, we’re beefing up our research in this segment. You can catch up on prior write-ups about psychedelics here and here.

We’ve also added 3 major drug companies who are specializing in the development of psychedelic compounds for therapeutic treatment of many psychological issues to our coverage list. These names are live on our research dashboard for ongoing tracking:

  • Atai Life Sciences (ATAI)
  • COMPASS Pathways (CMPS)
  • MindMed (MNMD)

While the world of psychedelic treatments are still in the early phases, it’s always better to be informed about potential opportunities.

In fact, we’re diving into 5 major companies leading what we’ve deemed the Healthcare Renaissance in our next MegaTrends report. These companies aren’t all involved in psychedelics, but they are leading the next wave of thought when it comes to health, wellness, and disease prevention.

Members can expect this report on Monday – we can’t wait!

Want deeper insights? Get Free Access to The Vault.

Related Posts

The Next Big Consumer Trend: Psychedelics

One of the fastest growing consumer macro trends in the […]

Read More
We Were Right about Psychedelics

In late July, a MAJOR emerging trend caught our eye: psychedelics. […]

Read More

Related Posts

Related Reports

About LikeFolio

LikeFolio analyzes social media data to accurately predict shifts in consumer behavior. We sell data and insights to professional investors, corporate research teams, and software providers.
© 2024
 LikeFolio. All Rights Reserved.